Trials / Terminated
TerminatedNCT00967642
Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)
Intravenous Insulin for 24 Hours in Patients With Diabetes Mellitus Submitted to Percutaneous Coronary Intervention With Stent: Effects Upon Oxidative Stress and Inflammatory Markers
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (planned)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant defense) and inflammation (C-reactive protein (CRP) and sCD40L) in diabetic patients submitted to PCI with stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous Insulin | continuous intravenous insulin/24h guided by glycemia (Optium, Abbott) evaluated hourly, targeting values lower than 110 mg/dl |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-07-01
- Completion
- 2009-04-01
- First posted
- 2009-08-28
- Last updated
- 2009-08-28
Source: ClinicalTrials.gov record NCT00967642. Inclusion in this directory is not an endorsement.